PhotonPharma
Fort Collins, US · Founded 2018 · Colorado corporation
PhotonPharma develops riboflavin and UV-based treatment technology (disposables and equipment) optimized for cancer immunotherapy and vaccine production. The company works with Colorado State University's School of Biomedical Engineering and external consultants to advance its immunotherapy platform.
Founders & leadership
MC
Milton ChangNamed on SEC filing
AR
Alan RudolphNamed on SEC filing
WB
Wolfgang BaikerNamed on SEC filing
GG
Gary GordonNamed on SEC filing
TO
Terry OpgenorthNamed on SEC filing
RG
Raymond GoodrichCo-founder
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 2 rounds · 2022–2024
▶$350KraisedMay 2024 · 2 investors · Other TechnologyRule 506(b)
▶$350KraisedMay 2024 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Terry OpgenorthDirector
- Wolfgang BaikerDirector
- Gary GordonDirector
- Raymond GoodrichDirector
- Alan RudolphExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $350K
- First sale
- May 2024
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$2.9MraisedAug 2023 · 8 investors · BiotechnologyRule 506(b)
▶$2.9MraisedAug 2023 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Milton ChangDirector
- Alan RudolphExecutive Officer, Director
- Wolfgang BaikerDirector
- Gary GordonDirector
- Terry OpgenorthDirector
- Raymond GoodrichDirector
- Offering amount
- $3.9M
- Amount sold
- $2.9M
- First sale
- Jan 2022
- Incorporated
- Corporation, Colorado, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Lyell12 shared keywordsLyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology. The company operates an integrated pipeline spanning discovery through manufacturing and clinical trials, with its own manufacturing facility in Washington.
Seeking Alpha9 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Radiuspharm8 shared keywordsRadius is a biopharmaceutical company focused on bone health and related therapeutic areas for underserved patient populations. It markets commercial products in the U.S., including TYMLOS (abaloparatide) injection and BINOSTO (alendronate sodium).
Companies competing with PhotonPharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does PhotonPharma do?
- PhotonPharma develops riboflavin and UV-based treatment technology (disposables and equipment) optimized for cancer immunotherapy and vaccine production. The company works with Colorado State University's School of Biomedical Engineering and external consultants to advance its immunotherapy platform.
- How much funding has PhotonPharma raised?
- PhotonPharma has disclosed $3.3M raised across 2 rounds.
- Where is PhotonPharma headquartered?
- PhotonPharma is headquartered in Fort Collins, US.